Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,093 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pediatric Screening: Development, Anemia, and Lead.
Wood SK, Sperling R. Wood SK, et al. Among authors: sperling r. Prim Care. 2019 Mar;46(1):69-84. doi: 10.1016/j.pop.2018.10.008. Epub 2018 Dec 22. Prim Care. 2019. PMID: 30704661 Review.
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.
Fortea J, Pegueroles J, Alcolea D, Belbin O, Dols-Icardo O, Vaqué-Alcázar L, Videla L, Gispert JD, Suárez-Calvet M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V. Fortea J, et al. Among authors: sperling r. Nat Med. 2024 May 6. doi: 10.1038/s41591-024-02931-w. Online ahead of print. Nat Med. 2024. PMID: 38710950
Atypical brain aging and its association with working memory performance in major depressive disorder.
Ho NCW, Bethlehem RA, Seidlitz J, Nogovitsyn N, Metzak P, Ballester PL, Hassel S, Rotzinger S, Poppenk J, Lam RW, Taylor VH, Milev R; Lifespan Brain Chart Consortium; Bullmore ET, Alexander-Bloch AF, Frey BN, Harkness KL, Addington J, Kennedy SH, Dunlop K. Ho NCW, et al. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Apr 26:S2451-9022(24)00110-1. doi: 10.1016/j.bpsc.2024.04.008. Online ahead of print. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38679324
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
Molina-Henry DP, Raman R, Liu A, Langford O, Johnson K, Shum LK, Glover CM, Dhadda S, Irizarry M, Jimenez-Maggiora G, Braunstein JB, Yarasheski K, Venkatesh V, West T, Verghese PB, Rissman RA, Aisen P, Grill JD, Sperling RA. Molina-Henry DP, et al. Among authors: sperling ra. Alzheimers Dement. 2024 Apr 17. doi: 10.1002/alz.13803. Online ahead of print. Alzheimers Dement. 2024. PMID: 38629508
1,093 results